Dr Jonathan Kell
MB, BChir, MD, FRCpath
I have been a Consultant Haematologist for 16 years specialising in the myeloid malignancies. I have contributed to writing the current UK guidelines for acute myeloid leukaemia and myelodysplasia and have wide-ranging clinical trial experience giving me insight into new and innovative treatment options.
I am particularly interested in acute myeloid leukaemia, myelodysplasia, myeloproliferative neoplasms, chronic myeloid leukaemia and haemochromatosis.
Until recently, I was Clinical Director for Haematology and Clinical Immunology at the University Hospital of Wales.
Spire Cardiff Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
FRCPath / London / 2002
MB, BChir / Cambridge / 1990